ROIV
Roivant's Explosive Growth: A Year of Breakthroughs and Record-Breaking Achievements
Roivant, a global biopharmaceutical company, has wrapped up an extraordinary fiscal year with a multitude of groundbreaking announcements and milestones. The recent Q4 2025 earnings call provided a comprehensive update on the company's progress, showcasing its unwavering commitment to innovation and patient care. The quarter was marked by